摘要
目的探讨疏血通注射液联合氯吡格雷治疗急性非ST段抬高心肌梗死的临床疗效。方法选取我院2016年1月至2017年6月收治的急性非ST段抬高心肌梗死患者60例,随机分为两组各30例。对照组常规给予氯吡格雷口服治疗,观察组在对照组基础上采用疏血通注射液治疗。两组均治疗10天。比较两组患者的疗效、cTnI、PBNP、缺血导联个数及ST段下移幅度。结果治疗后,对照组的cTnI、PBNP水平及ST段下移幅度、缺血导联个数均高于观察组(P<0.05)。观察组的总有效率明显高于对照组(P<0.05)。结论疏血通注射液联合氯吡格雷治疗急性非ST段抬高心肌梗死的临床效果显著,可有效降低患者中医证候积分,改善其心肌功能,值得推广应用。
Objective To explore the clinical curative effect of Shuxuetong injection combined with clopidogrel in the treatment of acute non ST segment elevation myocardial infarction. Methods 60 cases of patients with acute non ST segment elevation myocardial infarction admitted to our hospital from January 2016 to June 2017 were selected and randomly divided into two groups, with 30 cases in each group. The control group was treated with clopidogrel orally, while the observation group was treated with Shuxuetong Injection on the basis of control group. Both groups were treated for 10 days. The curative effect, c Tn I, PBNP, number of ischemic leads and range of ST segment depression were compared between the two groups. Results After treatment, the c Tn I and PBNP levels, range of ST segment depression and number of ischemic leads of the control group were higher than those of the observation group（P〈0.05）. The total effective rate of the observation group was significantly higher than that of the control group（P〈0.05）. Conclusions Shuxuetong injection combined with clopidogrel in the treatment of acute non ST segment elevation myocardial infarction has significant clinical effect, can effectively reduce the score of TCM syndrome and improve the myocardial function, which is worthy of promotion and application.
作者
黄平
HUA NG Ping(3^rd Department of Internal Medicine,Zhanjiang Second Hospital of Traditional Chinese Medicine,Zhanjiang 524000,China)
出处
《临床医学工程》
2018年第7期893-894,共2页
Clinical Medicine & Engineering
关键词
疏血通注射液
氯吡格雷
急性非ST段抬高心肌梗死
临床疗效
Shuxuetong injection
Clopidogrel
Acute non ST elevation myocardial infarction
Clinical curative effect
